1. Zaynoun ST, Aftimos BG, Tenekjian KK, Bahuth N, Kurban AK. Extensive pityriasis alba: a histological histochemical and ultrastructural study. Br J Dermatol. 1983; 108:83–90.
Article
2. Zaynoun S, Jaber LA, Kurban AK. Oral methoxsalen photochemotherapy of extensive pityriasis alba. Preliminary report. J Am Acad Dermatol. 1986; 15:61–65.
3. Dhai S, Kanwar AJ, Dawn G. Pigmenting pityriasis alba. Pediatr Dermatol. 1995; 12:197–198.
Article
4. Lin RL, Janniger CK. Pityriasis alba. Cutis. 2005; 76:21–24.
5. Sandhu K, Handa S, Kanwar AJ. Extensive pityriasis alba in a child with atopic dermatitis. Pediatr Dermatol. 2004; 21:275–276.
Article
6. Blessmann Weber M, Sponchiado de Avila LG, Albaneze R, Magalhães de Oliveira OL, Sudhaus BD, Cestari TF. Pityriasis alba: a study of pathogenic factors. J Eur Acad Dermatol Venereol. 2002; 16:463–468.
Article
7. Bassaly M, Miale A Jr, Prasad AS. Studies on pityriasis alba: a common facial skin lesion in Egyptian children. Arch Dermatol. 1963; 88:272–275.
8. Galadari E, Helmy M, Ahmed M. Trace elements in serum of pityriasis alba patients. Int J Dermatol. 1992; 31:525–526.
Article
9. Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol. 2007; (46):700–705.
Article
10. Rigopoulos D, Gregoriou S, Charissi C, Kontochristopoulos G, Kalogeromitros D, Georgala S. Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study. Br J Dermatol. 2006; 155:152–155.
Article